About Reprotox
A data base on the reproductive effects of chemicals, medications, physical agents, and biologics
REPROTOX contains summaries on the effects of medications, chemicals, biologics, and physical agents on pregnancy, reproduction, lactation, and development. The REPROTOX® system was developed as an adjunct information source for clinicians, scientists, and government agencies. Patients should consult their health care providers rather than relying on REPROTOX® summaries.
The only database that covers it all:
- Male and female fertility, pregnancy, lactation, and neonatal development
- Clinical, experimental animal, and in vitro studies
- More than 5,000 agents and exposures
Concise, up-dated, comprehensive summaries of the scientific literature.
Reprotox entries are written, updated, and reviewed by our staff:
Joan Garey, Ph.D., toxicology Sharon Lavigne, M.S., L.G.C., genetics Armand Lione, Ph.D., pharmacology and toxicology (retired) Shari I. Lusskin, M.D., reproductive psychiatry Ginger Nichols, M.S., L.C.G.C., genetics Anthony R. Scialli, M.D., reproductive and developmental toxicology